AYGEN, B. And YILDIZ, O. 2019. Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience. 17. Eoroasian Congress of Hepato-Gastroenterology and Surgery , (Croatia), 97-106.

AYGEN, B., & YILDIZ, O., (2019). Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience . 17. Eoroasian Congress of Hepato-Gastroenterology and Surgery (pp.97-106). , Croatia

AYGEN, BİLGEHAN, And ORHAN YILDIZ. "Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience," 17. Eoroasian Congress of Hepato-Gastroenterology and Surgery, Croatia, 2019

AYGEN, BİLGEHAN And YILDIZ, ORHAN. "Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience." 17. Eoroasian Congress of Hepato-Gastroenterology and Surgery , Croatia, pp.97-106, 2019

AYGEN, B. And YILDIZ, O. (2019) . "Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience." 17. Eoroasian Congress of Hepato-Gastroenterology and Surgery , Croatia, pp.97-106.

@conferencepaper{conferencepaper, author={BİLGEHAN AYGEN And author={ORHAN YILDIZ}, title={Ombitasvir/Paritaprevir/Ritonavir Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Reallife Practice: A Multicentre Experience}, congress name={17. Eoroasian Congress of Hepato-Gastroenterology and Surgery}, city={}, country={Croatia}, year={2019}, pages={97-106} }